Skip to Content

Tate & Lyle PLC TATE

Morningstar Rating
GBX 634.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

Company Report

Narrow-Moat Tate & Lyle Makes Good Progress Improving EBITDA in a Challenging Market Environment

Tate & Lyle, or T&L, is focused on the increasing use of alternative ingredients in food and beverage to remove unhealthy components (sugar, fat, salt), improve nutritional credentials through added fiber, and increase the shelf life of products. We assign the company a narrow moat, as we believe that efforts over the last few years to optimize the portfolio, culminating with the sale in 2022 of a controlling stake in the commoditized primary products business unit, have improved the company’s pricing power and competitive position.

Price vs Fair Value

TATE is trading at a 28% discount.
Price
GBX 646.50
Fair Value
GBX 313.00
Uncertainty
Medium
1-Star Price
GBX 8,982.00
5-Star Price
GBX 488.00
Economic Moat
Xhwsqmb
Capital Allocation
Rsjjxzdgq

Bulls Say, Bears Say

Bulls

Tate & Lyle’s portfolio is well positioned to benefit from secular trends that see consumers demanding healthier, safer, cleaner-label products.

Bears

The company is relying quite heavily on acquisitions in its attempt to expand its offering and capabilities, which may lead to expensive, value-destructive deals.

Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if TATE is a good fit for your portfolio.

News

Trading Information

Previous Close Price
GBX 634.00
Day Range
GBX 629.50642.50
52-Week Range
GBX 587.00837.50
Bid/Ask
GBX 0.00 / GBX 0.00
Market Cap
GBX 254.67 Bil
Volume/Avg
499,372 / 1.5 Mil

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
3.05%
Dividend Yield (Forward)
3.05%
Total Yield
4.39%

Company Profile

Tate & Lyle is a global provider of food and beverage ingredients and solutions. Following the sale in 2022 of a controlling stake in its commodity ingredients business, as well as its exit from the sugar business a decade earlier, Tate & Lyle is now focused on specialty ingredients—sweeteners, starches, and soluble fiber. It has 2,700 employees and operates in over 140 countries, with most of its revenue generated in North America.
Sector
Consumer Defensive
Industry
Packaged Foods
Stock Style Box
Mid Value
Total Number of Employees
4,591

Competitors

Valuation

Metric
TATE
IFF
INGR
Price/Earnings (Normalized)
36.2012.15
Price/Book Value
2.101.472.11
Price/Sales
1.870.94
Price/Cash Flow
22.547.83
Price/Earnings
TATE
IFF
INGR

Financial Strength

Metric
TATE
IFF
INGR
Quick Ratio
1.810.740.95
Current Ratio
2.881.671.92
Interest Coverage
−5.638.36
Quick Ratio
TATE
IFF
INGR

Profitability

Metric
TATE
IFF
INGR
Return on Assets (Normalized)
0.70%8.68%
Return on Equity (Normalized)
1.40%19.76%
Return on Invested Capital (Normalized)
1.90%12.55%
Return on Assets
TATE
IFF
INGR
See how this stock stacks up to its competitors with Morningstar Investor

Packaged Foods Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
NSRGY
Nestle SA ADRMmtjzhdcDkh$263.9 Bil
KHC
The Kraft Heinz CoPskhmrfshFzh$46.4 Bil
DANOY
Danone SA ADRDqvjgfhmZpqbh$41.1 Bil
GIS
General Mills IncXyfkbsndzMhybvq$39.0 Bil
MKC
McCormick & Co Inc Registered Shs Non VtgDrygwphpdJkb$20.3 Bil
K
Kellanova CoQpmzqbxvJkzhfj$20.0 Bil
HRL
Hormel Foods CorpMbrbpgymFwssh$19.3 Bil
CAG
Conagra Brands IncZrlbcyyxWrtjq$15.1 Bil
CPB
Campbell Soup CoDjbcxppQpc$13.5 Bil
SJM
JM Smucker CoBngyXxqx$12.2 Bil

Sponsor Center